PRESS RELEASE published on 03/31/2026 at 08:30, 5 months 11 days ago Quadient accompagne Lush Cosmetics dans la transformation de sa comptabilité fournisseurs avec sa solution d’automatisation Quadient accompagne Lush Cosmetics dans la transformation de sa comptabilité fournisseurs avec sa solution d'automatisation, permettant une optimisation des processus financiers Automatisation Optimisation Quadient Comptabilité Fournisseurs Lush Cosmetics
PRESS RELEASE published on 03/31/2026 at 08:30, 5 months 11 days ago Quadient Collaborates with Lush Cosmetics to Transform Accounts Payable Operations with its AP Automation Software Quadient collaborates with Lush Cosmetics to transform accounts payable operations with AP automation software, enhancing efficiency and controls Efficiency Quadient Finance Operations AP Automation Lush Cosmetics
PRESS RELEASE published on 03/25/2026 at 17:45, 5 months 16 days ago QUADIENT: Résultats annuels 2025 : Chiffre d'affaires de 1 036 millions d'euros, marge d’EBIT courant à 13,0 %
BRIEF published on 03/10/2026 at 08:35, 6 months 1 day ago Facturation électronique : 93 % des entreprises encore en chemin vers la conformité Conformité Facturation Électronique Quadient Réforme Plateforme Agréée
BRIEF published on 03/10/2026 at 08:35, 6 months 1 day ago Electronic invoicing: 93% of businesses still on the path to compliance Compliance Quadient Electronic Invoicing Reform Approved Platform
PRESS RELEASE published on 03/10/2026 at 08:30, 6 months 1 day ago Facturation électronique : à six mois de l’échéance, seules 7 % des entreprises sont pleinement prêtes À six mois de l'échéance, seules 7 % des entreprises sont prêtes pour la facturation électronique en France. Les entreprises progressent mais la conformité reste faible. Étude Quadient / OpinionWay Conformité Facturation Électronique Quadient Entreprises Observatoire
BRIEF published on 02/10/2026 at 08:35, 7 months 1 day ago Quadient strengthens its position with sustained digital growth Artificial Intelligence Automation Digital Growth Quadient Major Contracts
BRIEF published on 02/10/2026 at 08:35, 7 months 1 day ago Quadient renforce sa position avec une croissance numérique soutenue Contrats Majeurs Automatisation Intelligence Artificielle Croissance Numérique Quadient
BRIEF published on 02/10/2026 at 08:35, 7 months 1 day ago Quadient Digital enregistre une croissance historique au quatrième trimestre Expansion Mondiale Solutions D'automatisation Croissance Du Quadrant Performances Du T4 Réservations Financières
BRIEF published on 02/10/2026 at 08:35, 7 months 1 day ago Quadient Digital Sees Landmark Growth in Q4 Global Expansion Automation Solutions Q4 Performance Quadient Growth Financial Bookings
Published on 09/11/2026 at 04:00, 6 hours 7 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 42 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 47 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 7 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 47 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 2 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 7 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 7 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 7 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 37 minutes ago Availability of the 2026 Interim Financial Report